Core Viewpoint - The company has successfully completed the construction of a high-purity solvent project with an annual production capacity of 20,000 tons, which has effectively improved its capacity utilization rate [1] Group 1: Production and Capacity - The Changyi Tianyu project has officially commenced operations, leading to an increase in capacity utilization [1] - The company continues to solidify its position as a leading manufacturer of sartans, with a significant focus on the integration of raw materials and formulations [1] Group 2: Market Position and Revenue - The company's revenue from both raw materials and formulation products is showing a growth trend [1] - Several products have obtained CEP certification or are actively pursuing FDA certification, with revenue contributions expected to materialize as global market expansion progresses [1]
天宇股份:昌邑天宇已完成“年产2万吨高纯溶剂项目”工程建设,该项目已正式投入运行